NASDAQ : ALVR

AlloVir, Inc.

$9.81 USD

$0.39 (4.14%)

Volume
9.4K
Average Volume
22.94K
Market Capitalization
$49.48M
P/E Ratio
-2.04
Dividend Yield
0.00%
Price Target
Year High
$24.15
Year Low
$7.96
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$12.14
Company Overview

NASDAQ

Vikas Sinha CPA,

Biotechnology

Healthcare

ALVR

6

US

USD

https://www.allovir.com

617 433 2605

482929106

0001754068

Liquidity Metrics

0.02

12.14

12.14

4.26

0.00

Sales & Valuation

-$

0.00

1.52

-1.67

-2.07

Profitability

-$2.85

-$43.44M

0.00%

0.00%

-72.78%

-40.16%

P/E Metrics

-2.04

-0.01

-0.01

Analyst Price Target & Rating

N/A

0/5

8 Analysts

%

Poll Results

About AlloVir, Inc. (NASDAQ:ALVR) Stock

AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and C ... OVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.

Frequently Asked Questions

What is the current AlloVir, Inc. (ALVR) stock price?

AlloVir, Inc.(NASDAQ:ALVR) stock price is $9.81 in the last trading session. During the trading session, ALVR stock reached the peak price of $24.15 while $7.96 was the lowest point it dropped to. The percentage change in ALVR stock occurred in the recent session was 4.14% while the dollar amount for the price change in ALVR stock was $0.39.

ALVR's industry and sector of operation?

The NASDAQ listed ALVR is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of ALVR?

Brett R. Hagen | Chief Accounting Officer
David L. Hallal | Executive Chairman of the Board
Edward Miller | General Counsel & Secretary
Diana Brainard | Chief Executive Officer & Director
Cintia Piccina | Chief Commercial Officer

How many employees does ALVR have?

Number of ALVR employees currently stands at 6. ALVR operates from 1100 Winter Street, Waltham, MA 02451, US.

Link for ALVR official website?

Official Website of ALVR is: https://www.allovir.com

How do I contact ALVR?

ALVR could be contacted at phone #617 433 2605 and can also be accessed through its website. ALVR operates from 1100 Winter Street, Waltham, MA 02451, US.

How many shares of ALVR are traded daily?

The average number of ALVR shares traded daily for last 3 months was 22.94K.

What is the market cap of ALVR currently?

The market value of ALVR currently stands at $49.48M with its latest stock price at $9.81